Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
about
Prognostic gene expression profiling in esophageal cancer: a systematic reviewDistinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcomeOlfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart.SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapySystematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma.Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.Transcriptome analysis of the oriental fruit fly (Bactrocera dorsalis).TGM2: a cell surface marker in esophageal adenocarcinomas.The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinomaFOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas.Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.SOX15 governs transcription in human stratified epithelia and a subset of esophageal adenocarcinomasOsteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancerThe FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma.LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformationThe Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p.Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancerThree-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.Alterations in osteopontin modify muscle size in females in both humans and mice.GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation.Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma.The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer.A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression.The '-omics' revolution and oesophageal adenocarcinoma.Novel diagnostic and prognostic biomarkers in esophageal cancer.Plakophilins in desmosomal adhesion and signaling.Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma.Predictive genetic markers in neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: a long way to go. Review of the literature.Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.Deregulation of the FOXM1 target gene network and its coregulatory partners in oesophageal adenocarcinoma.κB-Ras proteins regulate both NF-κB-dependent inflammation and Ral-dependent proliferation.The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas.Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.Meta-analysis of the expression of the mitosis-related gene Fam83D.
P2860
Q28073948-C1D5761A-CA4A-41A0-8194-2897A6AD21B0Q28273187-6BD2F739-1843-42CF-B507-CE821F3398E9Q30539142-35182292-875F-4B8F-8FA0-3576447584E0Q33566670-595D398A-AF8A-4699-B805-5CC4C684C83AQ33648496-7C28992D-8B0B-47C7-A220-AE34B8A4EFA2Q33688989-15E0EEEC-2128-45C8-876F-DD28BBA893B9Q33779451-BB933AE8-69A8-4713-A318-7905E7EA0DA3Q33958974-BC6A9452-38E9-436E-9007-4FFD041EC47EQ34110743-483D246D-FB72-43C9-95AB-204A595D1700Q34219975-49179A4A-5CB9-4860-90E5-9807744BE65EQ34720904-6174E413-A187-41A1-8716-6C8E4D01A32CQ35843942-2BDA0665-E166-4A48-ACE2-6CC94C164CDCQ35922424-03324AEF-774D-4B2D-89A7-A73FDCDD31CBQ36206289-F283A8D0-3DFB-4892-9A4C-EE97DDAEE0A0Q36355935-951EA66E-6F44-4BF3-8115-C8C01AF73758Q36360734-02BA1839-D666-45AC-8E75-5BDFF4535AF5Q36385649-2F9E4C75-23F5-49DB-A006-647E031DD2EFQ36413145-09943BE5-2CF9-43A6-9FD8-86796952645AQ36437988-4AAA598D-8FE7-4E96-B24E-39D494220424Q36747368-C2FAF77E-D9AA-4F71-8938-FC7CEBBB62E5Q36763844-29F27FEA-AAEA-4A10-8AD6-B7EC1CB2C42DQ36781227-EEA5765A-4DB8-462E-B880-B2476CDED0D5Q37269021-150BDAAF-9095-4FE4-AB31-92F1F6146C95Q37533362-45093624-79EF-4493-8397-459A60DE1A00Q37559084-2C61313B-A05D-49BE-857D-8779384CD2BCQ37580308-01639AE2-EC58-4F2A-932B-BE71E98F1803Q37614505-F8B81DC8-8CE1-40F7-8F45-3347D2361D02Q37665380-F11A193E-EC66-4064-BA10-5AADE52FE734Q37738063-80A3D28D-5168-49F4-97CA-15B238A161B6Q38132057-1923B24B-B320-40BD-AF04-C9E02C7A3441Q38149245-00E63089-D298-45CC-90C5-EED1900658CEQ38181535-0C89E738-4A1E-4D9D-8A4D-D7A84500C993Q38599774-16C7C5A3-01D1-49B7-B6D5-8D3766F6560EQ38728693-B4D92CA1-973D-4CE4-9C38-AE75473FB5BCQ38827878-A1664E77-BA90-4001-B548-424BD0D5CA1FQ38885266-F6628C87-8F2B-430E-B593-C022EFC2F67AQ38956617-FA89D473-5BE9-4BE4-A5F4-D79607B56D5CQ38969484-B31D4AF8-FAE3-44ED-85FB-1DD08F15B4DCQ39110629-D24D423E-284E-4367-88AB-4F3F5A052F2BQ41955998-55256840-F258-4224-9F4E-A8F1DCC92BCE
P2860
Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prognostic biomarkers for esop ...... alysis of tumor transcriptome.
@ast
Prognostic biomarkers for esop ...... alysis of tumor transcriptome.
@en
type
label
Prognostic biomarkers for esop ...... alysis of tumor transcriptome.
@ast
Prognostic biomarkers for esop ...... alysis of tumor transcriptome.
@en
prefLabel
Prognostic biomarkers for esop ...... alysis of tumor transcriptome.
@ast
Prognostic biomarkers for esop ...... alysis of tumor transcriptome.
@en
P2093
P2860
P921
P1433
P1476
Prognostic biomarkers for esop ...... alysis of tumor transcriptome.
@en
P2093
Dipen Maru
Eun Sung Park
Jaffer A Ajani
Jeffrey H Lee
Ju-Seog Lee
Julie G Izzo
Kenneth K Wang
Manoop S Bhutani
Navtej S Buttar
P2860
P304
P356
10.1371/JOURNAL.PONE.0015074
P407
P577
2010-11-30T00:00:00Z